84-2183-10 [取扱停止]DNMT3B (DNA-methyltransferase 3B, ICF, ICF1, M.HsaIIIB) 50ul 210519
特徴
- CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation.
- Studies in mice have demonstrated that DNA methylation is required for mammalian development.
- This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation.
- The protein localizes primarily to the nucleus and its expression is developmentally regulated.
- Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome.
- Eight alternatively spliced transcript variants have been described.
- The full length sequences of variants 4 and 5 have not been determined.
- _
- Applications:Suitable for use in Western Blot.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:200-1:1000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:50ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by affinity chromatography.
- Form:Supplied as a liquid in PBS, pH 7.3, 0.02% sodium azide, 50% glycerol.
- Specificity:Recognizes human DNMT3B.
- Isotype:IgG
- Calc Applications Abbrev:WB
- Calc Crossreactivity:Hu
- Immunogen:Synthetic peptide corresponding to human DNMT3B.
- Shelf Life:1year
- Swiss Prot Number:Q9UBC3
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]